Myeloproliferative Disorders
Showing NaN - NaN of 7
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)
Not yet recruiting
- Myeloproliferative Disorders
- Leukemia
- Cardiac Lifestyle Program
-
Boston, Massachusetts
- +2 more
May 1, 2023
Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)
Recruiting
- Myeloproliferative Disorders
- +4 more
- ACE-536
- Placebo
-
La Jolla, California
- +184 more
Aug 22, 2022
Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic
Completed
- Leukemia
- +2 more
- Allogeneic bone marrow transplantation
- Peripheral blood stem cell transplantation
-
Birmingham, Alabama
- +44 more
Oct 24, 2017
AML, CML, MDS Trial in Boston, New York, San Antonio (STA-9090 (ganetespib))
Completed
- AML
- +3 more
- STA-9090 (ganetespib)
-
Boston, Massachusetts
- +2 more
Sep 17, 2014